Inhibition of viral replication in vitro by antiviral-treated amniotic membrane. Possible use of amniotic membrane as drug-delivering tool

British Journal of Ophthalmology

Volumn 95, Issue 1, 2011, Pages 28-31

  Mencucci, Rita ^a   Paladini, I ^a   Menchini, U ^a   Gicquel, J J ^b   Dei, R ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; TRIFLURIDINE;

AMNION; ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DRUG DELIVERY SYSTEM; DRUG EFFECT; HERPES SIMPLEX; NONHUMAN; PRIORITY JOURNAL; VERO CELL; VIRUS INHIBITION;

ACYCLOVIR; AMNION; ANIMALS; ANTIVIRAL AGENTS; CERCOPITHECUS AETHIOPS; COLONY COUNT, MICROBIAL; DRUG CARRIERS; HUMANS; SIMPLEXVIRUS; TRIFLURIDINE; VERO CELLS; VIRUS REPLICATION;

EID: 78650848387     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2010.179556     Document Type: Article

References (31)

1. Sorsby A, Symons HM. Amniotic membrane grafts in caustic burns of the eye: (burns of the second degree). Br J Ophthalmol 1946;30:337-45.
2. Dua HS, Gomes JA, King AJ, et al. The amniotic membrane in ophthalmology. Surv Ophthalmol 2004;49:51-77.
3. Azuara-Blanco A, Pillai CT, Dua HS. Amniotic membrane transplantation for ocular surface reconstruction. Br J Ophthalmol 1999;83:399-402. (Pubitemid 29161178)
4. Solomon A, Meller D, Prabhasawat P, et al. Amniotic membrane grafts for nontraumatic corneal perforations, descemetoceles, and deep ulcers. Ophthalmology 2002;109:694-703.
5. Sridhar MS, Bansal AK, Sangwan VS, et al. Amniotic membrane transplantation in acute chemical and thermal injury. Am J Ophthalmol 2000;130:134-7.
6. Tekin NF, Kaynak S, Saatci AO, et al. Preserved human amniotic membrane transplantation in the treatment of primary pterygium. Ophthalmic Surg Lasers 2001;32:464-9. (Pubitemid 33070075)
7. Ainsworth G, Rotchford A, Dua HS, et al. A novel use of amniotic membrane in the management of tube exposure following glaucoma tube shunt surgery. Br J Ophthalmol 2006;90:417-19.
8. Espana EM, Prabhasawat P, Grueterich M, et al. Amniotic membrane transplantation for reconstruction after excision of large ocular surface neoplasias. Br J Ophthalmol 2002;86:640-5.
9. Kee C, Hwang JM. Amniotic membrane graft for late-onset glaucoma filtering leaks. Am J Ophthalmol 2002;133:834-5.
10. Ti SE, Tow SL, Chee SP. Amniotic membrane transplantation in entropion surgery. Ophthalmology 2001;108:1209-17.
11. Solomon A, Espana EM, Tseng SC. Amniotic membrane transplantation for reconstruction of the conjunctival fornices. Ophthalmology 2003;110:93-100. (Pubitemid 36068732)
12. Nubile M, Carpineto P, Lanzini M, et al. Multilayer amniotic membrane transplantation for bacterial keratitis with corneal perforation after hyperopic photorefractive keratectomy: case report and literature review. J Cataract Refract Surg 2007;33:1636-40. (Pubitemid 47284765)
13. Gicquel JJ, Bejjani RA, Ellies P, et al. Amniotic membrane transplantation in severe bacterial keratitis. Cornea 2007;26:27-33.
14. Kim JS, Kim JC, Hahn TW, et al. Amniotic membrane transplantation in infectious corneal ulcer. Cornea 2001;20:720-6.
15. Singh R, Kumar D, Kumar P, et al. Development and evaluation of silver-impregnated amniotic membrane as an antimicrobial burn dressing. J Burn Care Res 2008;29:64-72.
16. King AE, Paltoo A, Kelly RW, et al. Expression of natural antimicrobials by human placenta and fetal membranes. Placenta 2007;28:161-9.
17. Mermet I, Pottier N, Sainthillier JM, et al. Use of amniotic membrane transplantation in the treatment of venous leg ulcers. Wound Repair Regen 2007;15:459-64. (Pubitemid 47087637)
18. Hasegawa T, Mizoguchi M, Haruna K, et al. Amnia for intractable skin ulcers with recessive dystrophic epidermolysis bullosa: report of three cases. J Dermatol 2007;34:328-32.
19. Mencucci R, Menchini U, Dei R. Antimicrobial activity of antibiotic-treated amniotic membrane: An in vitro study. Cornea 2006;25:428-31.
20. Knickelbein JE, Hendricks RL, Charukamnoetkanok P. Management of herpes simplex virus stromal keratitis: an evidence-based review. Surv Ophthalmol 2009;54:226-34.
21. O'Grady F, Lambert HP, Finch RG, et al, eds. Antibiotic and chemotherapy. London: Churchill and Livingstone, 1977.
22. Tseng SC, Prabhasawat P, Barton K, et al. Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch Ophthalmol 1998;116:431-41.
23. Lee SH, Tseng SC. Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am J Ophthalmol 1997;123:303-12.
24. Kruse FE, Rohrschneider K, Volcker HE. Multilayer amniotic membrane transplantation for reconstruction of deep corneal ulcers. Ophthalmology 1999;106:1504-10; discussion 11.
25. Heiligenhaus A, Bauer D, Meller D, et al. Improvement of HSV-1 necrotizing keratitis with amniotic membrane transplantation. Invest Ophthalmol Vis Sci 2001;42:1969-74.
26. Heiligenhaus A, Li H, Hernandez Galindo EE, et al. Management of acute ulcerative and necrotising herpes simplex and zoster keratitis with amniotic membrane transplantation. Br J Ophthalmol 2003;87:1215-19. (Pubitemid 37193908)
27. Heiligenhaus A, Li HF, Yang Y, et al. Transplantation of amniotic membrane in murine herpes stromal keratitis modulates matrix metalloproteinases in the cornea. Invest Ophthalmol Vis Sci 2005;46:4079-85.
28. Paradowska E, Blach-Olszewska Z, Sender J, et al. Antiviral nonspecific immunity of human placenta at term: possible role of endogenous tumor necrosis factors and interferons. J Interferon Cytokine Res 1996;16:941-8.
29. Bjorck L, Grubb A, Kjellen L, et al. a human proteinase inhibitor, blocks replication of herpes simplex virus. J Virol 1990;64:941-3. (Pubitemid 20032717)
30. Korant BD, Brzin J, Turk V. Cystatin, a protein inhibitor of cysteine proteases alters viral protein cleavages in infected human cells. Biochem Biophys Res Commun 1985;127:1072-6.
31. Ni J, Abrahamson M, Zhang M, et al. Cystatin E is a novel human cysteine proteinase inhibitor with structural resemblance to family 2 cystatins. J Biol Chem 1997;272:10853-8.